Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitesyntheticbiologic...
Twitter@SYNBiologics
CategoryBioTech
Phone(734) 332-7800
Emailinfo@adeonapharma...
Employees
Founded2001
DescriptionBiologics for the Prevention & Treatment

Offices

Rockville, USA
155 Gibbs Street, Suite 412
4th Floor for Reception
Rockville, MD, 20850
USA

People

Chief Executive Officer, President and Director
Chief Financial Officer
Chief Financial Officer
Executive Vice President, Research & Development

Funding

TOTAL $16.1M
FUNDING TOTAL $16.1M
Private Equity, 11/2012
$10.8M
Grant, 9/2013
Biotechnology and Biological Sciences Research Council (BBSRC)
Engineering and Physical Sciences Research Council (EPSRC)
£3.5M

Tags

Synthetic Biologics

Founded in 2001, Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol “SYN”.

The Company’s principal executive offices are located in Rockville, MD.

Synthetic Biologics, Inc. is a biotechnology company focused on the development of biologics for the prevention and treatment of serious infectious diseases. The Company is developing an oral enzyme for the prevention of C. difficile infections, and a series of monoclonal antibody therapies for the treatment of Pertussis and Acinetobacter infections.

In addition, the Company is developing a drug candidate for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis.

Recent Milestones

Videos

Screenshots

Synthetic Biologics screenshot
Above: Home Page
Uploaded: 7/11/13

Sources

  1. SEC (sec.gov) [edit]
  2. Tools and services for synthetic biology (innovateuk.org) [edit]
Edit This Page
Last Edited 12/11/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy